MacroGenics, Inc. (MGNX) vs Vogenx Inc. (VOGX)

A side-by-side comparison of MacroGenics, Inc. and Vogenx Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MGNX

MacroGenics, Inc.

$229M

$3.61HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT

VOGX

Vogenx Inc.

$227M

$16.31HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT

Total return — MGNX vs VOGX

growth of $100 · dividends reinvested · last 1y

MGNX -6.7% (-6.7%/yr)VOGX +31.9% (+31.9%/yr)VOGX compounded faster over this window

MGNX VOGX

Metrics side by side

Total return (annualized)

Metric	MGNX	VOGX
Total return (1Y)	111.04%	N/A
Total return CAGR (3Y)	-7.61%	N/A
Total return CAGR (5Y)	-28.42%	N/A
Total return CAGR (10Y)	-18.75%	N/A

VOGX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full MGNX analysis Full VOGX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.